Darin Dobler
Impact in
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
-
- Natural Antidiabetic Agents Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Advanced Glycation End Products research 4
-
- Cell Adhesion Molecules Research 3
- Co-authors
- Paul J. Thornalley (5 shared papers)Naila Ahmed (3 shared papers)Mark Dean (1 shared paper)Lijiang Song (1 shared paper)Kevin E. Eboigbodin (1 shared paper)Naila Rabbani (2 shared papers)Charles Streuli (1 shared paper)Natalie J. Gardiner (1 shared paper)
- Journals
- Annals of the New York Academy of Sciences (2 papers)Diabetes (2 papers)Cancers (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United KingdomSwitzerlandItaly
In The Last Decade
Darin Dobler
6 papers receiving 700 citations
Peers
Comparison fields: 5 of 81
- Clinical Biochemistry 449
- Endocrinology, Diabetes and Metabolism 163
- Physiology 186
- Pathology and Forensic Medicine 126
- Biochemistry 35
Countries citing papers authored by Darin Dobler
This map shows the geographic impact of Darin Dobler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darin Dobler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darin Dobler more than expected).
Fields of papers citing papers by Darin Dobler
This network shows the impact of papers produced by Darin Dobler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darin Dobler. The network helps show where Darin Dobler may publish in the future.
Co-authors
The 24 scholars most cited alongside Darin Dobler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 275 | |
| 2 | 2006 | 228 | |
| 3 | 2009 | 150 | |
| 4 | 2008 | 41 | |
| 5 | 2022 | 11 | |
| 6 | 2005 | 4 |
About Darin Dobler
Darin Dobler is a scholar working on Clinical Biochemistry, Immunology and Allergy, Oncology, Cancer Research and Molecular Biology, having authored 6 papers that have together received 709 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (4 papers), Cell Adhesion Molecules Research (3 papers), Protease and Inhibitor Mechanisms (2 papers), CAR-T cell therapy research (1 paper), Peptidase Inhibition and Analysis (1 paper), Alcohol Consumption and Health Effects (1 paper), Neurological Disorders and Treatments (1 paper) and Protein Interaction Studies and Fluorescence Analysis (1 paper). The work is most often cited by research in Clinical Biochemistry (449 citations), Endocrinology, Diabetes and Metabolism (163 citations), Physiology (186 citations), Pathology and Forensic Medicine (126 citations) and Biochemistry (35 citations). Darin Dobler has collaborated with scholars based in United Kingdom, Switzerland and Italy. Frequent co-authors include Paul J. Thornalley, Naila Ahmed, Mark Dean, Lijiang Song, Kevin E. Eboigbodin, Naila Rabbani, Charles Streuli, Natalie J. Gardiner, David R. Tomlinson and Sarah Moffatt. Their work appears in journals such as Annals of the New York Academy of Sciences, Diabetes, Cancers and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.